September EMA Rev

15 Inspections Human Medicines Pharmacovigilance Product name Active Substance s Reason s on list Marketing Authorisation Holder s Link to Product Information Date of Inclusion Adcetris Brentuximab vedotin New active substance

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document " September EMA Rev" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.